Overview

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.
Phase:
Phase 3
Details
Lead Sponsor:
Gynuity Health Projects
Treatments:
Mifepristone
Misoprostol